EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug

Alexander I P Taylor iD, Yong Xu, Martin Wilkinson, Pijush Chakraborty iD, Alice Brinkworth, Leon F Willis, Anastasia Zhuravleva, Neil A Ranson, Richard Foster iD, Sheena E Radford iD

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.4c16743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Alexander I P Taylor und 9 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, LS2 9…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Islet Amyloid Polypeptide, Canagliflozin, Amyloid. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Engineering and Physical Sciences Research Council, Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Islet Amyloid PolypeptideCanagliflozinAmyloidHypoglycemic AgentsKineticsHumans

Substanzen

Islet Amyloid PolypeptideCanagliflozinAmyloidHypoglycemic Agents

Autor:innen und Institutionen

  • Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, U.K.
  • Astbury Centre for Structural Molecular Biology, School of Chemistry, Faculty of Engineering and Physical Sciences, University of Leeds, LS2 9JT Leeds, U.K.

ORCID-Profile: Alexander I P Taylor, Pijush Chakraborty, Richard Foster, Sheena E Radford

Förderung

  • Wellcome Trust
  • Engineering and Physical Sciences Research Council
  • Royal Society
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Taylor, A. I. P., Xu, Y., Wilkinson, M., Chakraborty, P., Brinkworth, A., Willis, L. F., Zhuravleva, A., Ranson, N. A., Foster, R., & Radford, S. E. (2025). Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c16743

Vancouver

Taylor AIP, Xu Y, Wilkinson M, Chakraborty P, Brinkworth A, Willis LF, et al. Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c16743

BibTeX
@article{Taylor2025,
  author = {Taylor, Alexander I P and Xu, Yong and Wilkinson, Martin and Chakraborty, Pijush and Brinkworth, Alice and Willis, Leon F and Zhuravleva, Anastasia and Ranson, Neil A and Foster, Richard and Radford, Sheena E},
  title = {Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.4c16743}
}
Kostenlos starten →